The search for blood biomarkers that indicate risk of adverse neurodevelopmental outcomes in fetal growth restriction
Fetal growth restriction (FGR) impacts 5%-10% of pregnancies and is associated with increased risk of mortality and morbidity. Although adverse neurodevelopmental outcomes are observed in up to 50% of FGR infants, a diagnosis of FGR does not indicate the level of risk for an individual infant and th...
Saved in:
Main Authors: | Hannah Musco (Author), Kate Beecher (Author), Kirat K. Chand (Author), Roslyn N. Boyd (Author), Paul B. Colditz (Author), Julie A. Wixey (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Update of Fetal Growth Restriction Associated with Biomarkers
by: Liqun Sun, et al.
Published: (2022) -
Biomarker screening in fetal growth restriction based on multiple RNA-seq studies
by: Xiaohui Li, et al.
Published: (2023) -
Impact of early-onset fetal growth restriction on the neurodevelopmental outcome of very preterm infants at 24 months: a retrospective cohort study
by: Mariana Cortez Ferreira, et al.
Published: (2023) -
Hormonal Biomarkers for Evaluating the Impact of Fetal Growth Restriction on the Development of Chronic Adult Disease
by: Elizabeth Soares da Silva Magalhães, et al. -
Biomarkers to Enable Therapeutics Development in Neurodevelopmental Disorders
Published: (2020)